Replies to post #101 on 9 Meters Biopharma Inc (NMTRQ)

[EL CHAPO]

Pre market gap to $3.30+ tomorrow

[ClearlyStocks]

$INNT Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019

Let’s see if she crosses that $4 mark today.